Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-16Clinical Trial Update: PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity [Phase 3]
Phase 3 trial evaluating the preventive efficacy and safety of rebamipide for NSAID-induced mucosal toxicity in rheumatoid arthritis and rel…
-
CLINICAL_TRIALS research · 2011-11-15Clinical Trial Update: Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus
This clinical trial update describes a study evaluating ultrasound of the hands in patients with systemic lupus erythematosus, with rheumato…
-
FDA approval · 2011-11-08FDA Approved: NAPROXEN — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for a generic naproxen product. Naproxen is a nonsteroidal anti-inflammator…
-
FDA approval · 2011-10-31FDA Approved: MELOXICAM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Meloxicam from Aurobindo Pharma Limited. This approval updates the approved product under th…
-
FDA approval · 2011-10-28FDA Approved: LEFLUNOMIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Leflunomide from Apotex Corp.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy [Phase 3]
A Phase 3 trial evaluating ofatumumab in adults with rheumatoid arthritis who had an inadequate response to methotrexate was terminated, wit…
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis
This document provides an update on a completed clinical trial evaluating the safety and effectiveness of adalimumab in patients with rheuma…
-
CLINICAL_TRIALS trial_result · 2011-10-24Clinical Trial Update: Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients [Phase 1]
Phase 1 trial comparing safety and pharmacokinetics of two SAR153191 (REGN88) drug products in patients with rheumatoid arthritis; study com…
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: A Study of Tocilizumab in Patients With Rheumatoid Arthritis
The document reports a completed clinical trial evaluating tocilizumab in patients with rheumatoid arthritis, sponsored by Regeneron.
-
CLINICAL_TRIALS trial_result · 2011-10-07Clinical Trial Update: A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate [Phase 2]
Phase 2 study evaluating the safety and efficacy of rituximab in combination with methotrexate for moderate to severe rheumatoid arthritis; …
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Effectiveness of Water Exercises on Isokinetic Muscle Strength [Phase 3]
Phase 3 trial assessing water-based exercises to improve isokinetic muscle strength in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects [Phase 1]
A Phase 1 trial evaluated whether fostamatinib affects blood concentrations of digoxin in healthy volunteers and in subjects with rheumatoid…
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 proof-of-concept and dose-ranging trial in rheumatoid arthritis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2011-09-30Clinical Trial Update: Post-marketing Observational Study in Subjects With Rheumatoid Arthritis
A post-marketing observational study in subjects with rheumatoid arthritis sponsored by Abbott has completed and posted results (status: COM…
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis [Phase 4]
A Phase 4 study evaluating the optimal combination of methotrexate and adalimumab for early rheumatoid arthritis; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s) [Phase 3]
Phase 3 trial evaluating the safety and efficacy of Golimumab in active rheumatoid arthritis patients previously treated with anti-TNF biolo…
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: A Long-term Moderate Intervention With n-3 LC-PUFA-supplemented Dairy Products in Patients With Rheumatoid Arthritis [NA]
This update notes the completion of a long-term trial evaluating omega-3 fatty acid-enriched dairy products in patients with rheumatoid arth…
-
FDA approval · 2011-09-19FDA Approved: NAPROXEN — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s Naproxen under Original Application, making a generic naproxen product available. It is used to relieve pain a…
-
CLINICAL_TRIALS trial_result · 2011-09-15Clinical Trial Update: Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis
This clinical trial evaluating clinical remission in early aggressive rheumatoid arthritis has completed; Wyeth is now a subsidiary of Pfize…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate [Phase 2]
Phase 2 trial update evaluating two oral doses of PG-760564 in rheumatoid arthritis patients receiving methotrexate. The study is completed …
-
FDA approval · 2011-09-07FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Cimzia (certolizumab pegol) submitted by UCB, Inc. This action approves the changes described in…
-
FDA approval · 2011-09-07FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for SIMPONI (golimumab) filed by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption [NA]
A completed clinical trial reports that tumor necrosis factor decreases vitamin D–dependent calcium absorption in patients with rheumatoid a…
-
FDA approval · 2011-08-29FDA Approved: LEFLUNOMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Leflunomide (generic) submitted by Chartwell RX, LLC under an ANDA, enabling market authorizatio…
-
FDA approval · 2011-08-24FDA Approved: NAPROXEN — Original Application (Exelan Pharmaceuticals, Inc.)
The FDA approved Exelan Pharmaceuticals' original ANDA for Naproxen (generic naproxen). This confirms a generic naproxen product for arthrit…